Personalized Medicine: Seven Keys to Success

Compelling science doesn't always make a good commercial case. Here's how to tell the difference.

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Several years ago I tried to persuade a pharmaceutical product manager that coupling his successful drug with a diagnostic assay would boost its efficacy and safety. Although he agreed with my technical arguments, he said there was no possibility of introducing such an assay because doctors would drop the drug - one of many in its class - to the bottom of their priority list if patients first required testing. My suggestion of personalized medicine wasn't flawed from a scientific perspective, but it was destined for obscurity from a business sense because it meant the company would sell fewer drugs.

The lesson for companies involved with personalized medicine is clear: You can have the most compelling arguments in the world for using a particular diagnostic. But without a good commercial case, the project is most likely doomed.

As I learned several years ago, the realities of personalized medicine do not ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Stephen Little

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio